US3984384087 - GRFS - A1J1E2 (XNAS)
GRIFOLS, S.A. - AMERICAN DEPOSITARY SHARES Hinterlegungsschein
9,08 USD
Aktuelle Kurse von GRIFOLS, S.A. - AMERICAN DEPOSITARY SHARES
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
GRFS
|
USD
|
19.09.2024 22:00
|
9,08 USD
| 8,74 USD | 3,89 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | -1,94 % | 27,17 % | 29,34 % | 49,83 % | -6,87 % | -55,84 % |
Firmenprofil zu GRIFOLS, S.A. - AMERICAN DEPOSITARY SHARES Hinterlegungsschein
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic division researches, develops, produces, and commercializes diagnostic products that span the healthcare continuumfrom prevention, screening, diagnosis, and prognosis to disease and treatment monitoringto serve professionals. The Bio Supplies division provides biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.
Investierte Fonds
Folgende Fonds haben in GRIFOLS, S.A. - AMERICAN DEPOSITARY SHARES investiert:
Fonds | Vol. in Mio 58,85 | Anteil (%) 0,14 % |
Unternehmensdaten GRIFOLS, S.A. - AMERICAN DEPOSITARY SHARES Hinterlegungsschein
Name GRIFOLS, S.A. - AMERICAN DEPOSITARY SHARES
Firma Grifols, S.A.
Symbol GRFS
Website https://www.grifols.com
Heimatbörse
NASDAQ
WKN A1J1E2
ISIN US3984384087
Wertpapierart Hinterlegungsschein
Sektor Healthcare
Branche Drug Manufacturers - General
CEO Mr. Jose Ignacio Abia Buenache
Marktkapitalisierung 7 Mrd.
Land Spanien
Währung USD
Mitarbeiter 23,5 T
Adresse Avinguda de la Generalitat, 152, 08174 Barcelona
IPO Datum 2011-06-02
Aktien-Splits
Datum | Split |
---|---|
04.01.2016 | 2:1 |
11.12.2012 | 21:20 |
23.07.2012 | 1:2 |
01.12.2011 | 11:10 |
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | G0FB.F |
NASDAQ | GRFS |
Weitere Aktien
Investoren die GRIFOLS, S.A. - AMERICAN DEPOSITARY SHARES halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024